492 related articles for article (PubMed ID: 22431857)
1. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.
Doğan HO; Büyüktuna SA; Kapancik S; Bakir S
Arch Virol; 2018 Mar; 163(3):609-616. PubMed ID: 29159591
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
5. Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load.
Hasanoglu I; Guner R; Carhan A; Kocak Tufan Z; Yagci-Caglayik D; Guven T; Yilmaz GR; Tasyaran MA
J Clin Virol; 2016 Feb; 75():42-6. PubMed ID: 26780111
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever.
Menteşe A; Yilmaz G; Sümer A; Arslan M; Karahan SC; Köksal I
Int J Infect Dis; 2013 Nov; 17(11):e1042-5. PubMed ID: 23632301
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
[TBL] [Abstract][Full Text] [Related]
8. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods.
Kaya A; Engin A; Güven AS; Içağasıoğlu FD; Cevit O; Elaldı N; Gültürk A
Int J Infect Dis; 2011 Jul; 15(7):e449-52. PubMed ID: 21511509
[TBL] [Abstract][Full Text] [Related]
9. Identification and analysis of Crimean-Congo hemorrhagic fever virus from human sera in Tajikistan.
Atkinson B; Chamberlain J; Jameson LJ; Logue CH; Lewis J; Belobrova EA; Valikhodzhaeva M; Mullojonova M; Tishkova FH; Hewson R
Int J Infect Dis; 2013 Nov; 17(11):e1031-7. PubMed ID: 23764351
[TBL] [Abstract][Full Text] [Related]
10. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
11. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.
Onguru P; Dagdas S; Bodur H; Yilmaz M; Akinci E; Eren S; Ozet G
J Clin Lab Anal; 2010; 24(3):163-6. PubMed ID: 20486197
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
[TBL] [Abstract][Full Text] [Related]
14. [Two Crimean-Congo hemorrhagic fever cases without history of tick contact from Ankara region].
Kaya Kiliç E; Yilmaz U; Cesur S; Koçak Tufan Z; Kurtoğlu Y; Bulut C; Kinikli S; Irmak H; Demiröz AP
Mikrobiyol Bul; 2009 Oct; 43(4):677-81. PubMed ID: 20084924
[TBL] [Abstract][Full Text] [Related]
15. Parotitis associated with Crimean Congo hemorrhagic fever virus.
Kaya S; Yilmaz G; Ertunç B; Koksal I
J Clin Virol; 2012 Feb; 53(2):159-61. PubMed ID: 22079303
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.
Hekimoğlu HC; Demirci NA
Afr Health Sci; 2014 Dec; 14(4):873-81. PubMed ID: 25834496
[TBL] [Abstract][Full Text] [Related]
17. [Genetic variants of the Crimean-Congo hemorrhagic fever virus circulating in endemic areas of the southern Tajikistan in 2009].
Petrova ID; Kononova IuV; Chausov EV; Shestopalov AM; Tishkova FKh
Mol Gen Mikrobiol Virusol; 2013; (3):29-36. PubMed ID: 24364143
[TBL] [Abstract][Full Text] [Related]
18. Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?
Barut S; Dincer F; Sahin I; Ozyurt H; Akkus M; Erkorkmaz U
Int J Infect Dis; 2010 Jan; 14(1):e50-4. PubMed ID: 19487150
[TBL] [Abstract][Full Text] [Related]
19. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
Bakir M; Bakir S; Sari I; Celik VK; Gozel MG; Engin A
J Med Virol; 2013 Oct; 85(10):1794-801. PubMed ID: 23868816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
